Cargando…

Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension

Objective: Regulatory T cells (Tregs) are critical immune modulators to maintain immune homeostasis and limit pulmonary hypertension (PH). This study was aimed to identify Treg-related genes (TRGs) in PH. Methods: The gene expression profile from lungs of PH patients was retrieved from the Gene Expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Shi, Jun-Zhuo, Jiang, Rong, Liu, Shao-Fei, He, Yang-Yang, van der Vorst, Emiel P. C., Weber, Christian, Döring, Yvonne, Yan, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197497/ https://www.ncbi.nlm.nih.gov/pubmed/35712711 http://dx.doi.org/10.3389/fphar.2022.908783

Ejemplares similares

Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension
por: He, Yang-Yang, et al.
Publicado: (2021)

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension
por: He, Yang-Yang, et al.
Publicado: (2021)

G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
por: van der Vorst, Emiel P. C., et al.
Publicado: (2019)

MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015)

Chemokines and their receptors in Atherosclerosis
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015)

Gouty Offense in Patients With Obstructive Coronary Artery Disease Despite State‐of‐the‐Art Therapy
por: Döring, Yvonne, et al.
Publicado: (2018)

Inflammatory Chemokines in Atherosclerosis
por: Gencer, Selin, et al.
Publicado: (2021)

Advances in the research of sulfur dioxide and pulmonary hypertension
por: Liu, Xin, et al.
Publicado: (2023)

PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology
por: Sundararaman, Sai Sahana, et al.
Publicado: (2021)

Role of heparanase in pulmonary hypertension
por: Wang, Lin-Jun, et al.
Publicado: (2023)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
por: Xue, Zhifeng, et al.
Publicado: (2021)

Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis
por: Zhang, Ruihua, et al.
Publicado: (2022)

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose Tissue
por: Gencer, Selin, et al.
Publicado: (2021)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
por: Dong, Wenxing, et al.
Publicado: (2023)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition
por: Chen, Xing, et al.
Publicado: (2022)

Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis
por: Xiao, Xinghua, et al.
Publicado: (2022)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

Therapeutic Strategies in Pulmonary Hypertension
por: Fuso, Leonello, et al.
Publicado: (2011)

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Zhang, Min, et al.
Publicado: (2019)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
por: Shi, Yinan, et al.
Publicado: (2021)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
por: Li, Huayang, et al.
Publicado: (2021)

Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension
por: Jasemi, Seyed Vahid, et al.
Publicado: (2020)

Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway
por: Fu, Minyi, et al.
Publicado: (2021)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
por: Liu, Yang, et al.
Publicado: (2021)

Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Li, YiZhuo, et al.
Publicado: (2020)

Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway
por: Zuo, Wanyun, et al.
Publicado: (2021)

The Relationship Between Anti-Hypertensive Drugs and Cancer: Anxiety to be Resolved in Urgent
por: Yang, Rong, et al.
Publicado: (2020)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
por: Li, Jing-Hui, et al.
Publicado: (2019)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension
por: Fabro, Alexandre Todorovic, et al.
Publicado: (2021)

Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis
por: Wang, Pengwei, et al.
Publicado: (2022)

Low-dose of caffeine alleviates high altitude pulmonary edema via regulating mitochondrial quality control process in AT1 cells
por: Tian, Liuyang, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eh3sfptvdv2oqfpfeo1oidbns0